首页 > 专栏 > Annals of Oncology Current Issue Annals of Oncology Current Issue 共 100 条资讯 17P Association of lung immune prognostic index (LIPI) with survival of first line immune checkpoint inhibitors single agent or in combination with chemotherapy in untreated advanced NSCLC patients 2026-06-27 14:36:49 97P Impact of prior lines of systemic therapy (PST) on the efficacy of cemiplimab, a human monoclonal anti–PD-1, in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) 2026-06-27 14:36:49 86P A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 2026-06-27 14:36:49 148P NKG2E comprises an immunogenic peptide, derived from an alu-retrotransposon: An attractive novel target for immunotherapeutic approaches 2026-06-27 14:36:49 43P Enhancing the therapeutic effect of dendritic cell therapy by oncolytic adenovirus 3 encoding CD40-ligand 2026-06-27 14:36:49 98P Results from a phase I study of MK-1308 (anti–CTLA-4) plus pembrolizumab in previously treated advanced small cell lung cancer 2026-06-27 14:36:49 34P Development of LAG-3 nanobodies as potent cancer imaging tracers 2026-06-27 14:36:49 133P Tumour immune infiltrate characterization in luminal breast cancer in three distinct age categories and its correlation with frailty 2026-06-27 14:36:49 93O First results of phase I/II studies evaluating viral vector-based heterologous prime/boost immunotherapy against predicted HLA class I neoantigens demonstrate CD8 T cell responses in patients with advanced cancers 2026-06-27 14:36:49 74P Cost of adverse events (AEs) with second-line (2L) immuno-oncology agents (IO) and chemotherapy (CHEMO) in advanced non-small cell lung cancer (aNSCLC) in the real-world 2026-06-27 14:36:49 70P Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors 2026-06-27 14:36:49 164P Combined detection of CD137 and type 1 functions improves identification and characterization of the activated T lymphocyte repertoire 2026-06-27 14:36:49 109P Phase I clinical study for validation of fimaporfin-based photochemical internalisation: A novel technology for enhancing cellular immune responses important for therapeutic effect of peptide-and protein-based vaccines 2026-06-27 14:36:49 118P The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model 2026-06-27 14:36:49 156P T-cell and B-cell intratumoural interactions affect the progression of oropharyngeal squamous cell carcinoma 2026-06-27 14:36:49 23P Immunological signature meta-analysis across lung cancer cohorts within the NanoString Clinical Transcriptional Atlas Group (CTAG) associated with patient outcome and history 2026-06-27 14:36:49 145P Immune-competent 3D InSightTM tumour models as novel platform to assess combinatorial biologics therapy 2026-06-27 14:36:49 119P Final results of phase II trial (MIRACULUM) of the novel PD-1 inhibitor prolgolimab in patients with advanced melanoma 2026-06-27 14:36:49 18P The role of circulating neutrophils in the regulation of neoangiogenesis in ovarian cancer 2026-06-27 14:36:49 76P Real-world data analysis of PD-L1 expression and overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) 2026-06-27 14:36:49 « 上一页12345下一页 » 相关分类 Current Issue #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi 38号车评中心 3o米的微博